OSEASPRE CONSULTANTS LTD.

Classified under diversified commercial services, the entity reported nil revenue from operations in FY26, against Rs 18 lakh in FY25. Its total income of Rs 3.32 lakh in FY26 and Rs 2.29 lakh in Q1 FY27 came entirely from other income, with the Q1 net loss narrowing to Rs 2.59 lakh from Rs 3.64 lakh a year earlier. The company posted an FY26 net loss of Rs 18.28 lakh versus a Rs 3.98 lakh profit in FY25, with operating cash flow negative at Rs 21.92 lakh. Cash and cash equivalents jumped to Rs 209.83 lakh from Rs 0.77 lakh, driven by the sale of equity instruments worth Rs 178.52 lakh routed through other comprehensive income. In February 2026 it sold its entire holding of 48,000 equity shares in INOR Medical Products (an unlisted company) to Nowrosjee Wadia and Sons. Despite the operational loss, the board declared a Rs 87 per share dividend on a Rs 10 face value, and total comprehensive income was Rs 142.28 lakh. The entity has 22 shareholders on record and Rs 20 lakh of paid-up equity capital, with its registered office in Ballard Estate, Mumbai.